Delayed Visual Improvement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis - 31/12/21
Doi : 10.1016/j.pediatrneurol.2021.10.006
Alexandra B. Kornbluh, MD a, ⁎ 
, Grant T. Liu, MD b, Sarah E. Hopkins, MD, MSPH a
, Grant T. Liu, MD b, Sarah E. Hopkins, MD, MSPH a a Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
b Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
∗Communications should be addressed to: Dr. Kornbluh; Division of Neurology; Children's Hospital of Philadelphia; 3401 Civic Center Blvd; Philadelphia, PA 19104.Division of NeurologyChildren's Hospital of Philadelphia3401 Civic Center BlvdPhiladelphiaPA19104
Keywords : MOG, Optic neuritis, Pediatric, Outcomes
Plan
| Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 126
P. 43-45 - janvier 2022 Retour au numéro
Article précédent
- Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent
- Emily Malamud, Scott I. Otallah, James B. Caress, Daniel J. Lapid
- Cerebral Blood Flow Abnormalities Associated With Clinically Mild Encephalopathy With a Reversible Splenial Lesion Type 2
- Fumikazu Sano, Anna Kobayashi, Emi Sawanobori, Takeshi Inukai, Yoshimi Kaga
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?